Does Peter Attia recommend Berberine?
Peter Attia recommends Berberine in some contexts, but has also raised cautions.
Published research rates it moderate evidence. Of Peter Attia's 73 tracked claims, 31 are supported or partially supported by studies on PubMed.
Evidence last reviewed May 2026
Peter Attia on Berberine — 73 claims
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
For a patient who is insulin resistant or has mild type 2 diabetes and cannot tolerate metformin, berberine would be a reasonable consideration under medical supervision with attention to drug interactions.
The provided literature base includes a review specifically examining berberine as an alternative or add-on therapy to metformin (PMID: 34801530) and multiple meta-analyses and reviews addressing berb…
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
For a patient who is insulin resistant or has mild type 2 diabetes and cannot tolerate metformin, berberine would be a reasonable consideration under medical supervision with attention to drug interactions.
Several RCTs in the provided literature (PMIDs 18442638, 33024120, 34923903, 39998703) examine berberine in type 2 diabetes populations, lending biological plausibility to its use as a glucose-lowerin…
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
Berberine would be a reasonable consideration for a patient who is insulin resistant or has mild type 2 diabetes and cannot tolerate metformin, but only under medical supervision with attention to drug interactions — not as a casual supplement purchase.
The evidence supports berberine's efficacy for glucose and lipid management in insulin resistance and type 2 diabetes. The RCT (PMID: 18442638) directly compared berberine to metformin (0.5g TID, n=36…
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
For a patient who is insulin resistant or has mild type 2 diabetes and cannot tolerate metformin, berberine would be a reasonable consideration under medical supervision with attention to drug interactions.
The available literature includes a meta-analysis (PMID 32379652) and several reviews (notably PMID 34801530 reviewing berberine as alternative or add-on therapy to metformin) that collectively sugges…
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
For a patient who is insulin resistant or has mild type 2 diabetes and cannot tolerate metformin, berberine would be a reasonable consideration under medical supervision with attention to drug interactions.
The RCT by Zhang et al. (PMID 18442638) directly supports berberine's glucose-lowering efficacy in type 2 diabetes, showing comparable effects to metformin (0.5g TID) in 36 newly diagnosed patients. T…
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
For a patient who is insulin resistant or has mild type 2 diabetes and cannot tolerate metformin, berberine would be a reasonable consideration under medical supervision with attention to drug interactions.
The available literature includes a meta-analysis (PMID 32379652) on berberine's effects on obesity indices and a review explicitly comparing berberine as an alternative or add-on to metformin (PMID 3…
“If I had a patient who was insulin resistant or had mild type 2 diabetes and couldn't tolerate metformin, berberine would be a reasonable consideration — but under medical supervision with attention to drug interactions, not as a casual supplement purchase.”
Berberine would be a reasonable consideration for an insulin-resistant or mildly diabetic patient who cannot tolerate metformin, but only under medical supervision with attention to drug interactions — not as a casual supplement purchase.
The evidence supports berberine's efficacy for glucose and lipid metabolism in insulin-resistant and type 2 diabetic populations. The RCT (PMID 18442638) directly compared berberine to metformin (0.5g…
“The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
The glucose-lowering effect sizes of berberine are real and clinically meaningful for people with type 2 diabetes or prediabetes.
None of the 10 provided studies directly report key findings, populations, or limitations related to berberine's glucose-lowering effects in type 2 diabetes or prediabetes, as all 'Key finding,' 'Popu…
“The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
The glucose-lowering effect sizes of berberine are real and clinically meaningful for people with type 2 diabetes or prediabetes.
The provided literature includes RCTs (e.g., PMID 18442638, 33024120, 39998703) and a meta-analysis (PMID 32690176) that are directly relevant to berberine's glucose-lowering effects in type 2 diabete…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin.”
A meta-analysis of randomized controlled trials found that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes.
The expert's claim specifically references a meta-analysis of RCTs comparing berberine to metformin for fasting glucose and HbA1c reduction in type 2 diabetes. While the provided literature includes r…
“The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
The glucose-lowering effect sizes of berberine are real and clinically meaningful for people with type 2 diabetes or prediabetes.
None of the 10 retrieved studies directly report key findings, populations, or limitations relevant to berberine's glucose-lowering effect in type 2 diabetes or prediabetes, as all key finding fields…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin.”
A meta-analysis of randomized controlled trials found that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes.
None of the 10 retrieved studies directly address the specific claim that a meta-analysis of RCTs found berberine reduces fasting glucose and HbA1c comparably to metformin in type 2 diabetes. While PM…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin.”
A meta-analysis of randomized controlled trials found that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes.
None of the 10 retrieved studies directly address the specific claim that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes. While one review (PMID: 3480…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin.”
A meta-analysis of randomized controlled trials found that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes.
None of the 10 retrieved studies directly address the specific claim that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes patients via a meta-analysis…
“The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
The glucose-lowering effect sizes of berberine are real and clinically meaningful for people with type 2 diabetes or prediabetes.
None of the 10 provided studies directly address berberine's glucose-lowering effects in type 2 diabetes or prediabetes populations — the core of Attia's claim. The retrieved literature focuses primar…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin.”
A meta-analysis of randomized controlled trials found that berberine reduces fasting glucose and HbA1c at levels comparable to metformin in type 2 diabetes.
The provided literature includes an RCT (PMID: 18442638) directly comparing berberine to metformin (0.5g three times daily) in 36 newly diagnosed type 2 diabetes patients, finding comparable hypoglyce…
“The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
The glucose-lowering effect sizes of berberine are real and clinically meaningful for people with type 2 diabetes or prediabetes.
The RCT by Zhang et al. (PMID 18442638) directly supports the claim, showing berberine's hypoglycemic effect was comparable to metformin (0.5g TID) in 36 newly diagnosed type 2 diabetes patients over…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin. The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
A meta-analysis of RCTs found berberine produces reductions in fasting glucose and HbA1c comparable to metformin in people with type 2 diabetes.
The provided evidence includes an RCT (PMID: 18442638) that directly compared berberine to metformin (0.5g three times daily) in 36 newly diagnosed type 2 diabetes patients, showing comparable hypogly…
“A meta-analysis of randomized controlled trials found reductions in fasting glucose and HbA1c comparable to metformin. The effect sizes are real and clinically meaningful for people with type 2 diabetes or prediabetes.”
A meta-analysis of randomized controlled trials found that berberine produces reductions in fasting glucose and HbA1c comparable to metformin in people with type 2 diabetes.
The RCT by Zhang et al. (PMID: 18442638) directly compared berberine to metformin (0.5g three times daily) in 36 newly diagnosed type 2 diabetes patients over 3 months and found comparable hypoglycemi…
“it gets packaged and marketed in ways that I think outrun the evidence”
Berberine is marketed in ways that outrun the available evidence.
Attia's caution claim is partially supported by the evidence base provided. The available studies include several moderate-quality RCTs and reviews on berberine's effects on type 2 diabetes, lipid pro…
Other supplements Peter Attia discusses
Claims are extracted from publicly available podcasts and videos, attributed to their source, and compared against PubMed research. This is educational information only — consult a healthcare provider before starting any supplement.
Back to Peter Attia